TITLE

British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society

AUTHOR(S)
Johnston, I. D. A.; Prescott, R. J.; Chalmers, J. C.; Rudd, R. M.; Johnston, I D
PUB. DATE
January 1997
SOURCE
Thorax;Jan1997, Vol. 52 Issue 1, p38
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
66296646

 

Related Articles

  • Cryptogenic Fibrosing Alveolitis Predating Ulcerative Colitis. De Llano, Luis A. Pérez; Lancho, Angel; Del Cerro, J. L. Soilán; López-Rosés, Leopoldo // American Journal of Gastroenterology;Apr1996, Vol. 91 Issue 4, p822 

    Presents a letter to the editor on cryptogenic fibrosing alveolitis predating ulcerative colitis.

  • Preparing for practice Spirometry. Brennan, Kay // Update;Nov2006, Vol. 73 Issue 5, p97 

    The article offers information on spirometry which is an important diagnostic technique for chronic obstructive pulmonary disease (COPD). The use of spirometry in primary care has flourished because of its inclusion in key national guidelines on managing COPD, including the 2004 NICE Guidelines...

  • Cryptogenic fibrosing alveolitis and lung cancer: the BTS study. J M Harris // Thorax;Jan2010, Vol. 65 Issue 1, p70 

    BACKGROUND: The risk of lung cancer is often reported to be increased for patients with cryptogenic fibrosing alveolitis (CFA). METHODS: Vital status was sought for all 588 members of the British Thoracic Society (BTS) cryptogenic fibrosing alveolitis (CFA) study 11 years after entry to the...

  • Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis. Fellrath, J. M.; Du Bois, R. M. // Clinical & Experimental Medicine;Sep2003, Vol. 3 Issue 2, p65 

    Idiopathic pulmonary fibrosis (IPF), synonymous with cryptogenic fibrosing alveolitis (CFA), is a progressive and usually fatal disease of unknown cause characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. Historically, IPF/CFA encompassed a...

  • Minerva.  // BMJ: British Medical Journal (International Edition);04/11/98, Vol. 316 Issue 7138, p1178 

    Presents information on developments in medicine. Information on injuries from snowmobiles; Account on an approach for treating metastatic breast cancer; Survival period of patients with cryptogenic fibrosing alveolitis.

  • Fibrosing alveolitis in patients with RA. Saravanan, V.; Kelly, C. A. // Thorax;Apr2002, Vol. 57 Issue 4, p375 

    Presents a letter to the editor about fibrosing alveolitis in patients with rheumatoid arthritis.

  • Rising mortality from cryptogenic fibrosing alveolitis. Johnston, Ian; Britton, John; Kinnear, William; Logan, Richard // BMJ: British Medical Journal (International Edition);11/3/90, Vol. 301 Issue 6759, p1017 

    Examines the mortality rate caused by cryptogenic fibrosing alveolitis in Great Britain. Identification of factors important in the etiology of the disease; Assessment of the validity of death certification of the disease; Treatment and management of the disease.

  • Diagnosis and management of idiopathic pulmonary fibrosis. Walling, Anne D. // American Family Physician;5/15/1998, Vol. 57 Issue 10, p2527 

    Presents information from the article `Cryptogenic Fibrosing Alveolitis,' by M. Chang-Yeung and N.L. Muller, which was published in the 1997 August issue of the `Lancet' journal. Prevalence of idiopathic pulmonary fibrosis in the United States; Therapy used to treat pulmonary fibrosis;...

  • What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. Scott, Jonathan; Johnston, Ian; Britton, John // BMJ: British Medical Journal (International Edition);11/3/90, Vol. 301 Issue 6759, p1015 

    Examines the etiology of cryptogenic fibrosing alveolitis in Nottingham, England. Role of the occupational and domestic exposure to dust for the development of the disease; Survival of patients after a month of diagnosed; Evaluation of the restrictive pulmonary function test for the investigation.

  • What is this thing called CFA? Wells, A. U.; Hansell, D. M.; Nicholson, A. G. // Thorax;Jan2007, Vol. 62 Issue 1, p3 

    The article discusses various reports published within the issue, including one by R. Rudd, R.J. Prescott and JC Chalmers regarding cryptogenic fibrosing alveolitis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics